Fig 2: FucGM1 exhibits a superb differential tumour versus normal tissue distribution and is expressed in preclinical toxicology models A Comparative H-scores for DLL3 expression by PDX tissues (Supplemental Fig. 3A) compared to FucGM1 from [22]; B Comparative H-scores and staining for FucGM1, DLL3 and TTF-1 in patient SCLC samples (patient details in Supplemental Table 1); C H-score distribution of FucGM1 in squamous NSCLC tissues (staining in Supplemental Fig. 3C); D FucGM1 positive mouse tissues: (A) breast, (B) colon, (C) skeletal muscle, (D) pancreas, (E) skin, (F) small intestine (G) stomach (H) testes, (I) thymus, (J) Pituitary (C57BL/6); E FucGM1 positive rat tissues (A) mesothelium, (B) stomach (foveolar cells), (C) stomach (crypt cells); F FucGM1 positive cynomolgous monkey tissues: (A) thymus, (B) skin and (C) small intestine